Portugal, Sept. 14 -- Portugal based HIKMA FARMACEUTICA (PORTUGAL), S.A. has secured contract from Instit. Port. Oncologia Coimbra Francisco Gentil for 2026/0449 - Call For Proposals Under The Framework Agreement(S) 2023/0490 (Medicines Used In Skin Conditions), 2023/0491 (Oncological Medicines And Immunomodulators), 20 . The value of the contract is worth 15582 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....